Grifols (GRFS) has established a partnership with the Biomedical Advanced Research and Development Authority to test investigational ocular surface immunoglobulin eye drops for their ability to ...

Human albumin and IVIG are two of the main therapeutic plasma proteins Grifols' produces from donations of human blood plasma at dedicated donation centers across the United States." "Parkinson's ...

BARCELONA, Spain, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived ...

to back the take-private of Spanish pharmaceutical producer Grifols SA. Lenders are preparing to send final proposals next week, with the expectation that a bank group will be appointed by the end ...

Canadian fund Brookfield Corp. BN-T plans to offer about €7-billion ($10.4-billion) for Spanish drugmaker Grifols SA after finishing due diligence, news website El Confidencial reported on ...

Brookfield still hasn't managed to obtain the €9.5 billion of bank financing to repay Grifols’ debt, nor the €3.5 billion it ...